Red blood cells as potential materials for microRNA biomarker study: overcoming heparin-related challenges.
Am J Physiol Heart Circ Physiol
2024
327
5
H1296-H1302
Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis.
Nat Commun
2024
15
1
Inflammatory crosstalk impairs phagocytic receptors and aggravates atherosclerosis in clonal hematopoiesis in mice.
J Clin Invest
2024
135
1
PIEZO1 targeting in macrophages boosts phagocytic activity and foam cell apoptosis in atherosclerosis.
Cell Mol Life Sci
2024
81
1
Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis.
Nat Cardiovasc Res
2024
3
1
60-75
Noncoding RNAs in the Vasculature: Basic Mechanisms and Therapeutic Perspectives.
Arterioscler Thromb Vasc Biol
2024
44
1
3-6
Myeloid cannabinoid CB1 receptor deletion confers atheroprotection in male mice by reducing macrophage proliferation in a sex-dependent manner.
Cardiovasc Res
2024
120
12
1411-1426
Mustn1 is a smooth muscle cell-secreted microprotein that modulates skeletal muscle extracellular matrix composition.
Mol Metab
2024
82
High-Dimensional Single-Cell Multimodal Landscape of Human Carotid Atherosclerosis.
Arterioscler Thromb Vasc Biol
2024
44
4
930-945
Atherosclerosis Is a Smooth Muscle Cell-Driven Tumor-Like Disease.
Circulation
2024
149
24
1885-1898